Skip to main content
. 2022 Sep 1;27:168. doi: 10.1186/s40001-022-00798-6

Fig. 3.

Fig. 3

Proposed mechanism of action of preclinical targets. CSF cerebrospinal fluid, SPAK SPS1-related proline/alanine-rich kinase, TLR4 toll-like receptor 4, TRPV4 transient receptor potential vanilloid 4, NKCC1 sodium potassium 2-chloride cotransporter 1. Figure created in BioRender